HBV polymerase interacts independently with N-terminal and C-terminal fragments of Hsp90β

Biochemical and Biophysical Research Communications

Volumn 274, Issue 1, 2000, Pages 203-211

  Cho, Ginam ^a   Suh, Se Won ^a   Jung, Guhung ^a  

^a Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CHAPERONE; DNA POLYMERASE; HEAT SHOCK PROTEIN 90; STEROID RECEPTOR;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN PROTEIN INTERACTION;

EID: 0033931516     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2000.3119     Document Type: Article

References (34)

1. Pratt W. B., Toft D. O. Steroid receptor interactions with heat shock protein and immunophilin chaperones. Endocr. Rev. 18:1997;306-360.
2. Pratt W. B. The role of the hsp90-based chaperone system in signal transduction by nuclear receptors and receptors signaling via MAP kinase. Annu. Rev. Pharmacol. Toxicol. 37:1997;297-326.
3. Bohen S. P., Yamamoto K. R. Morimoto R., Tissieres A., Georgopoulos C. The Biology of Heat Shock Proteins and Molecular Chaperones. 1994;313-334 Cold Spring Harbor Laboratory Press, Plainview.
4. Blagosklonny M. V., Toretsky J., Bohen S., Neckers L. Mutant conformation of p53 translated in vitro or in vivo requires functional HSP90. Proc. Natl. Acad. Sci. USA. 93:1996;8379-8383.
5. Scheibel T., Neuhofen S., Weikl T., Mayr C., Reinstein J., Vogel P. D., Buchner J. ATP-binding properties of human Hsp90. J Biol. Chem. 272:1997;18608-18613.
6. Prodromou C., Roe S. M., O'Brien R., Ladbury J. E., Piper P. W., Pearl L. H. Identification and structural characterization of the ATP/ADP-binding site in the Hsp90 molecular chaperone. Cell. 90:1997;65-75.
7. Stebbins C. E., Russo A. A., Schneider C., Rosen N., Hartl F. U., Pavletich N. P. Crystal structure of an Hsp90-geldanamycin complex: Targeting of a protein chaperone by an antitumor agent. Cell. 89:1997;239-250.
8. Scheibel T., Weikl T., Buchner J. Two chaperone sites in Hsp90 differing in substrate specificity and ATP dependence. Proc. Natl. Acad. Sci. USA. 95:1998;1495-1499.
9. Young J. C., Schneider C., Hartl F. U. In vitro. 418:1997;139-143.
10. Jibard N., Meng X., Leclerc P., Rajkowski K., Fortin D., Schweizer-Groyer G., Catelli M. G., Baulieu E. E., Cadepond F. Delimitation of two regions in the 90-kDa heat shock protein (Hsp90) able to interact with the glucocorticosteroid receptor (GR). Exp. Cell Res. 247:1999;461-474.
11. Sullivan W. P., Toft D. O. Mutational analysis of hsp90 binding to the progesterone receptor. J. Biol. Chem. 268:1993;20373-20379.
12. Buchner J. Hsp90 & Co. - A holding for folding. Trends Biochem. Sci. 24:1999;136-141.
13. Garcia-Cardena, G., Fan, R., Shah, V., Sorrentino, R., Cirino, G., Papapetropoulos, A., and Sessa, W. C.Dynamic activation of endothelial nitric oxide synthase by Hsp90. Nature392, 821-824.
14. Holt, S. E., Aisner, D. L., Baur, J., Tesmer, V. M., Dy, M., Ouellette, M., Trager, J. B., Morin, G. B., Toft, D. O., Shay, J. W., Wright, W. E., and White, M. A.Functional requirement of p23 and Hsp90 in telomerase complexes. Genes Dev.13, 817-826.
15. Hu J., Seeger C. Hsp90 is required for the activity of a hepatitis B virus reverse transcriptase. Proc. Natl. Acad. Sci. USA. 93:1996;1060-1064.
16. Ganem D., Varmus H. E. The molecular biology of the hepatitis B viruses. Annu. Rev. Biochem. 56:1987;651-693.
17. Seeger C., Summers J., Mason W. S. Viral DNA synthesis. Curr. Top. Microbiol. Immunol. 168:1991;41-60.
18. Summers J., Mason W. S. Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate. Cell. 29:1982;403-415.
19. Gotte M., Li X., Wainberg M. A. HIV-1 reverse transcription: A brief overview focused on structure-function relationships among molecules involved in initiation of the reaction. Arch. Biochem. Biophys. 365:1999;199-210.
20. Bartenschlager R., Schaller H. The amino-terminal domain of the hepadnaviral P-gene encodes the terminal protein (genome-linked protein) believed to prime reverse transcription. EMBO J. 7:1988;4185-4192.
21. Wang G. H., Seeger C. The reverse transcriptase of hepatitis B virus acts as a protein primer for viral DNA synthesis. Cell. 71:1992;663-670.
22. Weber M., Bronsema V., Bartos H., Bosserhoff A., Bartenschlager R., Schaller H. Hepadnavirus P protein utilizes a tyrosine residue in the TP domain to prime reverse transcription. J. Virol. 68:1994;2994-2999.
23. Zoulim F., Seeger C. Reverse transcription in hepatitis B viruses is primed by a tyrosine residue of the polymerase. J. Virol. 68:1994;6-13.
24. Hu J., Toft D. O., Seeger C. Hepadnavirus assembly and reverse transcription require a multi-component chaperone complex, which is incorporated into nucleocapsids. EMBO J. 16:1997;59-68.
25. Cho G., Park S. G., Jung G. Localization of HSP90 binding sites in the human hepatitis B virus polymerase. Biochem. Biophys. Res. Commun. 269:2000;191-196.
26. Guan K. L., Dixon J. E. Eukaryotic proteins expressed in Escherichia coli: An improved thrombin cleavage and purification procedure of fusion proteins with glutathione S-transferase. Anal. Biochem. 192:1991;262-267.
27. Summers M. D., Smith G. E. A manual of methods for baculovirus vectors and insect cell culture procedures. Tex. Agric. Exp. Stn. Bull. 1555:1987;1-48.
28. Luckow V. A., Lee S. C., Barry G. F., Olins P. O. Efficient generation of infectious recombinant baculoviruses by site-specific transposon-mediated insertion of foreign genes into a baculovirus genome propagated in Escherichia coli. J. Virol. 67:1993;4566-4579.
29. Park J. H., Choi E. A., Cho E. W., Hahm K. S., Kim K. L. Maltose binding protein (MBP) fusion proteins with low or no affinity to amylose resins can be single-step purified using a novel anti-MBP monoclonal antibody. Mol. Cells. 8:1998;709-716.
30. Meng X., Devin J., Sullivan W. P., Toft D., Baulieu E. E., Catelli M. G. Mutational analysis of Hsp90 alpha dimerization and subcellular localization: Dimer disruption does not impede "in vivo" interaction with estrogen receptor. J. Cell Sci. 109:1996;1677-1687.
31. Nemoto T., Sato N., Iwanari H., Yamashita H., Takagi T. Domain structures and immunogenic regions of the 90-kDa heat-shock protein (HSP90). Probing with a library of anti-HSP90 monoclonal antibodies and limited proteolysis. J. Biol. Chem. 272:1997;26179-26187.
32. Wearsch P. A., Nicchitta C. V. Endoplasmic reticulum chaperone GRP94 subunit assembly is regulated through a defined oligomerization domain. Biochemistry. 35:1996;16760-16769.
33. Maruya M., Sameshima M., Nemoto T., Yahara I. Monomer arrangement in HSP90 dimer as determined by decoration with N and C-terminal region specific antibodies. J. Mol. Biol. 285:1999;903-907.
34. Nemoto T., Ohara-Nemoto Y., Ota M., Takagi T., Yokoyama K. Mechanism of dimer formation of the 90-kDa heat-shock protein. Eur. J. Biochem. 233:1995;1-8.